Last reviewed · How we verify
NCT06069817: HiSTENT
Impact of High Flow Therapy on Complications Related to Airway Stenting
NA trial testing High flow nasal cannula in Airway Obstruction in 30 participants. Status unknown.
1 November 2024
Quick facts
| Lead sponsor | Cardarelli Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 January 2024 |
| Primary completion | 1 November 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- High flow nasal cannula
- nebulized normal saline — full drug profile →
Conditions studied
- Airway Obstruction — all drugs for Airway Obstruction →
- Respiratory Infection — all drugs for Respiratory Infection →
- Mucus; Plug — all drugs for Mucus; Plug →
Sponsor
Cardarelli Hospital
Who can join
18 and older, any sex, with Airway Obstruction or Respiratory Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The application of HFNC therapy in patients with airway stent, improving both humidification and clearance of the airway secretion, could potentially reduce the risk of mucoid impaction, respiratory infections and granulation. HFNC therapy could be superior to nebulization of normal saline (usual care) in order to keep the stent cleaned, reducing, by inference, the risk of complications, as defined above.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06069817
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High flow nasal cannula
Trials testing the same drug.
- NCT05918575 — Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients · NA · recruiting
- NCT05532033 — High Flow Nasal Cannula and Diaphragmatic Function · NA · completed
- NCT04842253 — HFNC Vs LFNC in Patients with AF Undergoing RFCA Under Deep Sedation. · NA · terminated
- NCT04849520 — High Flow Nasal Cannula for Safe Apnea · NA · completed
- NCT04711759 — Physiologic Effects of High-flow Nasal Cannula Versus Standard Oxygen Therapy Postextubation in Critically Ill Patients · NA · completed
Other recruiting trials for Airway Obstruction
Currently open trials in the same condition.
- NCT05974488 — The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE · NA · recruiting
- NCT03049202 — BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study · active not recruiting
Other Cardarelli Hospital trials
Trials by the same sponsor.
- NCT07295886 — Topical Nifedipine 0.3% Plus Lidocaine 1.5% for Uncomplicated Hemorrhoidal Disease · recruiting
- NCT06438939 — NBI for Early Diagnosis of OPMD/OSCC · NA · not yet recruiting
- NCT04728412 — High Flow Oxygen Therapy in Patients Undergoing Bronchoscopy Under Sedation · NA · unknown
- NCT04148677 — Protoves M1® Syrup in Controlling Adverse Event During HIVEC® Instillations · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06069817 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardarelli Hospital
- Last refreshed: 13 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06069817.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing